Trial Profile
Phase Ib study of POL-6014 in patients with non-cystic fibrosis bronchiectasis (NCFB)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2022
Price :
$35
*
At a glance
- Drugs Lonodelestat (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions
- 04 Nov 2016 New trial record